Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma

NCT01208194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Colorectal Carcinoma

Interventions

DRUG: MGN1703
DRUG: Placebo

Sponsor

Mologen AG